Does CBD Oil Cause Man Boobs? What the Evidence Says

Does CBD oil give you man boobs? It is a question more men are asking as CBD products become increasingly popular across the UK. Gynaecomastia, the benign enlargement of glandular breast tissue in males, has several well-established causes, but whether CBD oil belongs on that list is far less clear. This article examines what the current evidence says about CBD oil and male hormone levels, explores the many other causes of gynaecomastia that should be ruled out first, and explains when to seek medical advice about changes in your chest.

Can CBD oil really cause gynaecomastia (enlarged breast tissue)?

There is no established clinical evidence that CBD oil directly causes gynaecomastia; most concern relates to high-THC cannabis rather than the low-THC CBD oils legally sold in the UK.

There is no established clinical evidence that CBD oil directly causes gynaecomastia in men. Gynaecomastia refers to the benign enlargement of glandular breast tissue in males, and it is driven primarily by an imbalance between oestrogen and androgen activity in breast tissue.^[10][11] While some men using cannabis products have reported breast changes, the research specifically linking CBD oil (cannabidiol) to gynaecomastia remains very limited and largely anecdotal.

It is important to distinguish between CBD oil and cannabis more broadly. Cannabis contains many compounds, including tetrahydrocannabinol (THC), which has been more closely studied in relation to hormonal effects. CBD products sold legally in the UK must contain no more than 1 mg of THC per container under Home Office guidance on controlled cannabinoids, meaning the hormonal exposure from a compliant CBD product is very different from that of recreational cannabis use.^[2][3] Consumer CBD products are regulated as novel foods by the Food Standards Agency (FSA) in England, Wales and Northern Ireland, and by Food Standards Scotland (FSS) in Scotland, unless medicinal claims are made, in which case MHRA oversight applies.^[4][5]

That said, the endocannabinoid system does interact with hormonal pathways, and researchers are still working to understand the full implications of regular CBD use on male reproductive hormones. Until larger, well-designed clinical trials are available, it is not possible to say with certainty that CBD oil is entirely without hormonal effect. Men who notice breast tissue changes while using CBD oil should not assume CBD is the cause without first ruling out other, more common explanations.

How might CBD oil affect hormone levels in men?

CBD may interact with the endocannabinoid system and certain liver enzymes, but the clinical significance for male hormone levels in humans at typical supplement doses remains unclear.

CBD oil may interact with the endocannabinoid system in ways that could theoretically influence hormone regulation, though the clinical significance of this in humans remains unclear. The endocannabinoid system plays a modulatory role in the hypothalamic-pituitary-gonadal (HPG) axis, which governs the production of testosterone, luteinising hormone (LH), and follicle-stimulating hormone (FSH).^[7] Some animal studies have suggested that cannabinoids, particularly THC, can suppress LH secretion, which in turn could reduce testosterone production, but these findings have not been consistently replicated in human trials and should not be directly attributed to CBD without specific human evidence.^[13][14]

Some laboratory research has raised the hypothesis that CBD may interact with certain cytochrome P450 enzymes, including CYP19A1 (aromatase), the enzyme responsible for converting androgens into oestrogens. If aromatase activity were reduced, this might theoretically lower oestrogen levels rather than raise them, which would be inconsistent with a mechanism for gynaecomastia. However, the clinical relevance of this in living humans at typical supplement doses is not established, and findings across studies have pointed in different directions.

It is also worth noting that some commercially available CBD oils contain carrier oils and other botanical extracts. There are isolated case reports linking certain plant-derived ingredients, such as lavender or tea tree oil, to hormonal effects, though the evidence for clinically meaningful effects from CBD carrier oils at typical doses is weak.^[8][9] Men with concerns about hormonal health should discuss their supplement use, including CBD oil, with their GP before drawing conclusions.

What does the current evidence say about CBD and oestrogen?

Current evidence does not support a direct link between CBD oil and raised oestrogen in men; CBD does not appear to act as a classical oestrogen receptor agonist.

Current evidence does not support a direct link between CBD oil use and raised oestrogen levels in men. Most of the concern around cannabis and oestrogen relates to THC-dominant cannabis rather than isolated CBD, and even that evidence base is inconsistent. A small number of case reports have described gynaecomastia in men who used cannabis heavily, but these cases typically involved high-THC products rather than the low-THC CBD oils available legally in the UK.

Some preclinical studies have explored CBD's interaction with oestrogen receptors, but findings have been mixed. CBD does not appear to act as a classical oestrogen receptor agonist, meaning it does not straightforwardly mimic oestrogen in the way that some pharmaceutical compounds or phytoestrogens do. The WHO's critical review of cannabidiol, published by the Expert Committee on Drug Dependence, found no evidence of public health risk or abuse potential and noted a generally favourable safety profile, though it acknowledged that human data on endocrine effects remain limited.

The FSA in England, Wales and Northern Ireland, and FSS in Scotland, have noted that evidence on long-term safety, including endocrine effects, is still being gathered. This regulatory caution reflects genuine scientific uncertainty rather than confirmed harm. Men should treat claims that CBD oil definitively causes or prevents hormonal changes with scepticism until more robust human data are available.

Are there other causes of gynaecomastia you should rule out first?

Far more common causes of gynaecomastia include obesity, liver disease, prescribed medicines such as spironolactone or finasteride, and hormonal fluctuations, all of which should be excluded before blaming CBD oil.

Gynaecomastia has many well-established causes that are far more likely than CBD oil to explain breast tissue changes in men. The most common underlying factors include hormonal fluctuations during puberty, age-related changes in testosterone and oestrogen balance, obesity (which increases peripheral aromatisation of androgens to oestrogens), liver disease, kidney disease, and hyperthyroidism.^[6] In many cases, no specific cause is identified and the condition is described as idiopathic.

A wide range of prescribed medicines is strongly associated with gynaecomastia. Well-established examples include:

• Spironolactone and other anti-androgens

• Anabolic steroids and testosterone replacement therapy

• Finasteride and other 5-alpha reductase inhibitors

• Cimetidine and related H2 antagonists

• Some antipsychotics (which raise prolactin)

• Digoxin and certain other cardiac medicines

• Opioid analgesics used long-term

Proton pump inhibitors such as omeprazole have been mentioned in case reports, though the association is considered weak and debated; they are listed here for completeness rather than as established culprits. Recreational drug use, including anabolic steroid misuse, alcohol excess, and cannabis (particularly high-THC products), is also a recognised contributor. Rarer causes include testicular tumours, adrenal tumours, and pituitary disorders, all of which require prompt investigation.

Before attributing breast changes to CBD oil, a GP will typically take a thorough medication and supplement history and examine the chest to distinguish glandular tissue from fatty tissue (pseudogynaecomastia). Blood tests commonly arranged include testosterone, oestradiol, LH, FSH, prolactin, beta-hCG, liver function, and thyroid function.^[10][12] Testicular ultrasound may be requested if a testicular cause is suspected, and further imaging considered if an adrenal or pituitary cause is possible. Identifying the correct cause matters because some underlying conditions require specific treatment in their own right. NICE clinical knowledge summaries on gynaecomastia provide detailed UK guidance on assessment and referral thresholds.

What side effects and risks should men know about before using CBD oil?

Common side effects of CBD oil include fatigue, diarrhoea, and dry mouth; a more significant risk is inhibition of CYP450 enzymes, which can alter the metabolism of medicines such as warfarin.

CBD oil is generally considered to have a reasonable short-term safety profile in adults, but men should be aware of several documented and potential risks before using it. The most commonly reported side effects include fatigue, diarrhoea, changes in appetite, and dry mouth. These effects are typically mild and dose-dependent.

A more clinically significant concern is CBD's inhibition of cytochrome P450 liver enzymes, particularly CYP3A4, CYP2C19, and CYP2C9. This can alter the metabolism of a range of prescribed medicines. Warfarin, which is primarily metabolised by CYP2C9, is one example where case reports have documented raised INR values in people using CBD alongside anticoagulation; other affected medicines include certain antiepileptics and some statins. Men taking any regular medication should speak to their GP or pharmacist before starting CBD oil to check for potential interactions.

Liver enzyme elevations have been reported in clinical trials of high-dose pharmaceutical CBD (Epidyolex), though those doses are considerably higher than those found in typical food supplement products.^[18] Nevertheless, men with pre-existing liver conditions should exercise caution.

The FSA advises that healthy adults should not exceed 70 mg of CBD per day from food supplements over a long period, and separately provides a lower consumer guidance figure of 10 mg per day for everyday use.^[5] FSS provides equivalent advice for consumers in Scotland. The FSA and FSS both advise that people who are pregnant or breastfeeding should avoid CBD products. People with liver conditions or those taking other medicines should seek medical advice before use.

If you experience an unexpected side effect from a CBD product, this can be reported to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk), which accepts reports from both patients and healthcare professionals. Men who notice breast tenderness, swelling, or nipple discharge alongside CBD use should speak to their GP. If you are concerned about a side effect, it is reasonable to pause a non-essential supplement such as CBD oil and seek advice from your GP or pharmacist before deciding whether to continue.

Should you speak to a GP if you notice changes in your chest?

Yes, men with new breast swelling, tenderness, a hard lump, or nipple discharge should see their GP promptly, as breast changes can occasionally indicate conditions requiring urgent investigation.

Yes, men who notice new or progressive breast tissue enlargement, breast tenderness, or nipple discharge should speak to their GP, regardless of whether they are using CBD oil or any other supplement. While gynaecomastia is usually benign, breast changes in men can occasionally indicate an underlying condition that requires investigation, including, in rare cases, male breast cancer. A GP can examine the tissue, take a history, and arrange appropriate tests to identify or exclude serious causes.

You should contact your GP if you notice:

• Unilateral (one-sided) breast swelling, which is more likely to need investigation than symmetrical changes

• A hard, irregular, or fixed lump in the breast tissue

• Nipple discharge, particularly if bloodstained

• Skin changes over the breast, such as dimpling or redness

• Breast changes accompanied by testicular pain or swelling

For red-flag features such as a rapidly growing or suspicious lump, your GP may refer you urgently under the NICE NG12 suspected cancer pathway (two-week-wait referral) to exclude malignancy.^[19] If you are unable to reach your GP and need urgent advice, NHS 111 can help direct you to the appropriate service. A&E is appropriate only for life-threatening emergencies.

If your GP suspects a hormonal cause, they may refer you to an endocrinologist or, if a structural cause is identified, to a surgeon. Men who are considering or already using CBD oil as part of a broader wellness plan may find it helpful to discuss this with a clinician who can review their full health picture. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations with prescriber review and pharmacist support, where clinically appropriate options can be discussed. Being open with your healthcare team about all supplements you take, including CBD oil, is always advisable, and pausing a non-essential supplement pending clinical review is a reasonable step if you have concerns.

Scientific References

1. Sativex Oromucosal Spray Summary of Product Characteristics.
2. Drug licensing factsheet: cannabis, CBD and other cannabinoids.
3. Guidance on analytical limits for controlled cannabinoids.
4. CBD novel food applications: recommendations to ministers on first authorisations.
5. Cannabidiol (CBD) guidance.
6. Peripheral aromatization as a risk factor for breast and other cancers.
7. Phytocannabinoids, the Endocannabinoid System and Male Reproduction.
8. Prepubertal Gynecomastia Linked to Lavender and Tea Tree Oils.
9. Prepubertal gynecomastia linked to lavender and tea tree oils [PubMed record].
10. Gynecomastia in adolescent males: current understanding of its etiology, pathophysiology, diagnosis, and treatment.
11. Gynecomastia in Infants, Children, and Adolescents.
12. Gynecomastia: physiopathology, evaluation and treatment.
13. Effects of delta 9-THC and castration on behavior and plasma hormone levels in male mice.
14. In vitro effects of cannabinoids on follicular function in the rat.
15. Marihuana and alcohol: perinatal effects on development of male reproductive functions in mice.
16. Inhibitory effects of Δ8-tetrahydrocannabinol on major hepatic cytochrome P450 enzymes and implications for drug disposition.
17. Interaction between warfarin and cannabis.
18. Cannabidiol and Liver Enzyme Level Elevations in Healthy Adults.
19. Suspected cancer: recognition and referral (NG12).

Frequently Asked Questions